Daniel Curran Founder of Timberlyne Therapeutics Backed byAbingworthAnthony Montagu, Peter DicksCarlos Paya LinkedIn SourcesTimberlyne: 80 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders — 2025-01 Browse all founders · Browse investors
